SEC Form 4 · accession 0000899243-16-026069
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Richman
Director
Period of report
Jul 25, 2016
Accepted (ET)
Aug 1, 2016 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.73 | Jul 25, 2016 | A | 9,144 | A | Jul 25, 2016 | Jul 25, 2026 | Common Stock | 9,144 | 9,144 | D |